Leiden University

Two methods published simultaneously in Science use the Illumina MiSeq instrument to help increase the throughput of single-molecule biophysics studies.

A recent study has found that a polygenic risk score of more than 300 variants could shift what screening recommendations for breast cancer women might receive.

Researchers have developed a computational method that considers uncommon CYP2D6 variants to assess patient-specific metabolism of tamoxifen and other drugs.